002821 Asymchem Laboratories(Tianjin)Co.,Ltd.
Trading 06-23 10:11:09
129.19
+3.38
+2.69%
High129.97Low124.13Vol3.84M
Open125.10D1 Closing125.81Amplitude4.64%
Mkt Cap46.64BTradable Cap40.95BTotal Shares361.00M
T/O491.00MT/O Rate1.21%Tradable Shares317.00M
P/B2.53ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Asymchem to Repurchase and Cancel 117,500 Restricted A-Shares
Stock News  ·  06-17
Asymchem to Repurchase and Cancel 117,500 Restricted A-Shares
Asymchem Allocates 3.54 Million Yuan for Share Buyback on June 12
Stock News  ·  06-12
Asymchem Allocates 3.54 Million Yuan for Share Buyback on June 12
Asymchem files HKEX next-day disclosure reporting share repurchase cancellation
Reuters  ·  06-12
Asymchem files HKEX next-day disclosure reporting share repurchase cancellation
Asymchem Laboratories Announces Completion of Repurchase and Cancellation of Restricted A Shares Under 2025 Plan
Stock News  ·  06-12
Asymchem Laboratories Announces Completion of Repurchase and Cancellation of Restricted A Shares Under 2025 Plan
Asymchem Laboratories to Distribute Final Dividend of RMB 13 per 10 Shares on July 24
Stock News  ·  06-10
Asymchem Laboratories to Distribute Final Dividend of RMB 13 per 10 Shares on July 24
Fuguo Fund Management Increases Stake in Asymchem by 53,300 Shares at Average Price of HK$98.28
Stock News  ·  05-28
Fuguo Fund Management Increases Stake in Asymchem by 53,300 Shares at Average Price of HK$98.28
AsymBio, Asymchem unit, showcases bioconjugate Conjugation Toolbox for ADC process development
Reuters  ·  05-27
AsymBio, Asymchem unit, showcases bioconjugate Conjugation Toolbox for ADC process development
JPMorgan Reduces Stake in Asymchem by 67,700 Shares at HK$98.5 per Share
Stock News  ·  05-27
JPMorgan Reduces Stake in Asymchem by 67,700 Shares at HK$98.5 per Share
Asymchem Laboratories Surges Over 7% on Robust Emerging Business Performance and Institutional Confidence in Long-Term Growth
Stock News  ·  05-21
Asymchem Laboratories Surges Over 7% on Robust Emerging Business Performance and Institutional Confidence in Long-Term Growth
Citigroup's Long Position in H Shares of Asymchem Laboratories (Tianjin) Decreases to 4.99% on May 14 From 5.66% - HKEX
THOMSON REUTERS  ·  05-20
Citigroup's Long Position in H Shares of Asymchem Laboratories (Tianjin) Decreases to 4.99% on May 14 From 5.66% - HKEX
Asymchem Laboratories to Distribute Final Dividend of RMB 13 per 10 Shares on July 24
Stock News  ·  05-15
Asymchem Laboratories to Distribute Final Dividend of RMB 13 per 10 Shares on July 24
Asymchem proposes final dividend of RMB 13 per 10 shares for FY2025
Reuters  ·  05-15
Asymchem proposes final dividend of RMB 13 per 10 shares for FY2025
Asymchem Laboratories Tianjin announces shareholder meetings
Reuters  ·  05-15
Asymchem Laboratories Tianjin announces shareholder meetings
Citigroup's Long Position in H-Shares of Asymchem Laboratories (Tianjin) Decreases to 5.36% on May 7 From 5.91% - HKEX
THOMSON REUTERS  ·  05-13
Citigroup's Long Position in H-Shares of Asymchem Laboratories (Tianjin) Decreases to 5.36% on May 7 From 5.91% - HKEX
Citigroup's Long Position in H-Shares of Asymchem Laboratories (Tianjin) Decreases to 7.11% on Apr 28 From 9.86% - HKEX
THOMSON REUTERS  ·  05-05
Citigroup's Long Position in H-Shares of Asymchem Laboratories (Tianjin) Decreases to 7.11% on Apr 28 From 9.86% - HKEX
BRIEF-JPMorgan Chase’s Long Position In H-Shares Of Asymchem Laboratories (Tianjin) Decreases To 7.64% On Apr 28 From 8.18%, HKEX Filing Shows
Reuters  ·  05-04
BRIEF-JPMorgan Chase’s Long Position In H-Shares Of Asymchem Laboratories (Tianjin) Decreases To 7.64% On Apr 28 From 8.18%, HKEX Filing Shows
JPMorgan Chase’s Long Position in H-Shares of Asymchem Laboratories (Tianjin) Decreases to 7.64% on April 28 From 8.18% - HKEX Filing
THOMSON REUTERS  ·  05-04
JPMorgan Chase’s Long Position in H-Shares of Asymchem Laboratories (Tianjin) Decreases to 7.64% on April 28 From 8.18% - HKEX Filing
Schroders PLC Reduces Stake in Asymchem by 258,900 Shares at HK$113.53 Each
Deep News  ·  04-30
Schroders PLC Reduces Stake in Asymchem by 258,900 Shares at HK$113.53 Each
Norges Bank Reduces Stake in Asymchem by 184,900 Shares at HK$102.86 Per Share
Stock News  ·  04-29
Norges Bank Reduces Stake in Asymchem by 184,900 Shares at HK$102.86 Per Share
Bocom International Raises Asymchem's Target Price to HK$136.6, Keeps Buy Rating
Stock News  ·  04-29
Bocom International Raises Asymchem's Target Price to HK$136.6, Keeps Buy Rating

Introduction

Company Name.
凯莱英医药集团(天津)股份有限公司
Industry:
医药制造业
Listing Date:
2016-11-18
Main Business:
　　凯莱英医药集团(天津)股份有限公司的主营业务是为国内外制药公司、生物技术公司提供药品全生命周期的一站式服务。公司的主要产品是小分子CDMO解决方案、新兴业务。凯莱英生物AsymBio偶联药物开发平台成功入围第12届WorldADCAwards“BestADCPlatformTechnology”奖项，印证了凯莱英生物在全球抗体偶联药物CDMO领域的卓越地位。
Issue price:
30.53